Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen nanogel for dental sensitivity after in-office bleaching
RBR-4ng46xjPhase 1Recruiting
- Sponsor
- Universidade Federal do Rio Grande do Norte
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, triple-blind trial of ibuprofen in Dentinal hypersensitivity (DH) (2 arms), sponsored by Universidade Federal do Rio Grande do Norte. Primary endpoint: Dental pain intensity after bleaching. Started Mar 2024; status: recruiting.
02
Drugs
ibuprofen
03
Conditions
Dentinal hypersensitivity (DH)
Beyond the preview
Go deeper on RBR-4ng46xj.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4ng46xj.